Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer

por Mross, Klaus, Frost, Annette, Scheulen, Max E, Krauss, Jürgen, Strumberg, Dirk, Schultheiss, Beate, Fasol, Ulrike, Büchert, Martin, Krätzschmer, Jörn, Delesen, Heinz, Rajagopalan, Prabhu, Christensen, Olaf
Publicado 2011

DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study

por Mross, Klaus, Fasol, Ulrike, Frost, Annette, Benkelmann, Robin, Kuhlmann, Jan, Büchert, Martin, Unger, Clemens, Blum, Hubert, Hennig, Jürgen, Milenkova, Tsveta P, Tessier, Jean, Krebs, Annetta D, Ryan, Anderson J, Fischer, Richard
Publicado 2009